Skip to content
  • Company

Company Rank

0

Country Rank

SR Score

0

SR Web

0

SR Social

0

Edimer Pharmaceuticals develops a treatment to improve the health and quality of life of families living with XLHED.

Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). XLHED is a rare orphan disease that causes a range of symptoms including lack of sweat glands, poor te...
See More

Website: https://edimerpharma.com

Founded: January 01, 2009

Social:

 SR Traffic - Month

 Ahrefs

X

Edimer Biotech Competitors

Add Competitor

Startup Industry Description
NeuroX1
Pharmaceuticals & Biotechnology The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...
MDacne
Healthcare Equipment & Services Treating Acne Was never this Easy - MDAlgorithms developed a Mobile App platform to di ...
BetterHealthcare
Healthcare Equipment & Services A better care experience for all - At BetterHealthcare, our passion is to transform y ...
View more competitors»

Edimer Biotech Funding

Add Funding

Date Round Amount Investors
Jul 30, 2013 Series B $ 18,000,000
Nov 01, 2010 Grant Undisclosed amount
Jun 30, 2009 Series A $ 22,000,000
View more funding rounds»

Edimer Biotech Acquisitions

Add Acquisition

Date Acquired Amount
There are no acquisitions.

Edimer Biotech Products

Add Product

Product Stage Description
There are no products.

Edimer Biotech Team

Add Team Member

Person Role Period
Neil Kirby
Founder Unknown to Unknown

Edimer Biotech News

Add News

Date Title
There are no news.

Edimer Biotech Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers